Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
FDA · 17 medicines
CBG-MEB · 14 medicines
AEMPS · 11 medicines
TFDA · 10 medicines
PHARMAC · 7 medicines
SFDA · 7 medicines · Historical list
MS · 5 medicines · Historical list
HSA · 5 medicines
HALMED · 2 medicines
AIFA · 2 medicines
EMA · 1 medicine
ALIMS · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
17 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Propranolol Hydrochloride | United States | 20MG/5ML, 40MG/5ML | solution | Marketed | Hikma |
| Propranolol Hydrochloride | United States | 1MG/ML, 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable | Marketed | Smith and Nephew |
| Propranolol Hydrochloride | United States | 10MG, 20MG, 40MG … | tablet | Marketed | Schering |
| Propranolol Hydrochloride | United States | 120MG, 160MG, 60MG … | capsule, extended release | Marketed | Adare Pharms INC |
| Propranolol Hydrochloride & HydrochlorothiazideCombination | United States | 25MG; 40MG, 25MG; 80MG | tablet | Not marketed | Duramed Pharms Barr |
| Propranolol Hydrochloride Intensol | United States | 80MG/ML | concentrate | Not marketed | Roxane |
| Propranolol Hydrochloride and HydrochlorothiazideCombination | United States | 25MG; 40MG, 25MG; 80MG | tablet | Not marketed | Warner Chilcott |
| Hemangeol | United States | 4.28MG/ML | solution | Marketed | Eton |
| Innopran XL | United States | 120MG, 80MG | capsule, extended release | Marketed | Ani Pharms |
| Inderal LA | United States | 120MG, 160MG, 60MG … | capsule, extended release | Marketed | Ani Pharms |
| Inderal | United States | 10MG/ML | suspension | Not marketed | Wyeth Ayerst |
| Inderal | United States | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … | tablet | Not marketed | Wyeth Pharms |
| Inderide-40/25Combination | United States | 25MG; 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Wyeth Pharms INC |
| Inderide-80/25Combination | United States | 25MG; 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Wyeth Pharms INC |
| Inderide LA 120/50Combination | United States | 50MG; 120MG | capsule, extended release | Not marketed | Wyeth Ayerst |
| Inderide LA 160/50Combination | United States | 50MG; 160MG | capsule, extended release | Not marketed | Wyeth Ayerst |
| Inderide LA 80/50Combination | United States | 50MG; 80MG | capsule, extended release | Not marketed | Wyeth Ayerst |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
